Stellavon 8

OTC

Indications

• Secretolytic therapy in acute and chronic bronchopulmolnary diseases associated with abnormal mucus secretion and impaired mucus transport.

Dosage

• Adults and children over 12 years: 8 mg (1 tablet) three times daily. Adults may increase the dose to 48 mg/day.
• Children 6-12 years: 4 mg (half a tablet) three times daily.
• Children 2-6 years: 4 mg (half a tablet) twice daily.
• This medication is not recommended for the elderly, and those with renal or hepatic impairment.

Administration

• Orally administered with a full glass of water.

• Known to be hypertensitive to bromhexine or other components of the formulations.
• Children under 2 years.

Possible adverse reactions:

• Gastrointestinal disorders (Nausea, vomiting, diarrhea and upper abdominal pain including gastralgia.)
• Risk of increased bronchial congestion in some patients unable to expectorate effectively.

• The combination of bromhexine with cough suppressants is irrational as there is a risk of mucus buildup in the respiratory tract.
• If cases of severe skin reactions such as erythema multiforme, Stevens-Johnson syndrome (SSJ)/Lyell’s syndrome and acute generalized exanthematous pustulosis (AGEP) are present, bromhexine should be discontinued.
• Bromhexine precipitates in a solution with a pH greater than 6. This tablet should not be dissolved in a solution.
• Stellavon 8 contains lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.
• Bromhexine should not be used by pregnant or breastfeeding women.
• Bromhexine has not been observed to affect the ability to drive or operate machinery.